<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-164812" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Avoidant Restrictive Food Intake Disorder</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramirez</surname>
            <given-names>Zerimar</given-names>
          </name>
          <aff>BronxCare Health System</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Gunturu</surname>
            <given-names>Sasidhar</given-names>
          </name>
          <aff>ICAHN School of Medicine at Mt. Sinai</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Zerimar Ramirez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sasidhar Gunturu declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-164812.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Avoidant restrictive food intake disorder (ARFID) represents a distinct entity established by the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) within the spectrum of feeding and eating disorders. ARFID is characterized by significant limitations in food intake leading to malnutrition, weight loss, or nutritional deficiency, without the concurrent body image disturbances typically seen in anorexia nervosa or bulimia nervosa.<xref ref-type="bibr" rid="article-164812.r1">[1]</xref>&#x000a0;Individuals with ARFID display avoidance or restriction of food intake, often due to sensory issues, fear-related avoidance of eating, or low appetite, leading to nutritional deficiencies, weight loss, and psychosocial impairments.&#x000a0;ARFID&#x000a0;can occur at any age but typically arises in childhood and can persist into adulthood. Furthermore, this condition may also occur with other medical or psychiatric disorders, complicating both diagnosis and treatment.<xref ref-type="bibr" rid="article-164812.r2">[2]</xref>&#x000a0;Adding to the diagnostic complexity, ARFID manifests differently in individuals, with an array of symptoms across the 3 significant drivers of the disorder, making it a challenging disorder.<xref ref-type="bibr" rid="article-164812.r3">[3]</xref>&#x000a0;</p>
        <p>The DSM-V outlines criteria for diagnosing ARFID, emphasizing the absence of body image disturbance and ruling out other eating disorders or medical conditions as the cause. Diagnosis involves a comprehensive medical, nutritional, and psychological evaluation to assess the patient's physical health, eating behaviors, and mental well-being.&#x000a0;Treatment for ARFID focuses on addressing immediate health concerns, restoring nutritional health, expanding food variety, and addressing fears or discomforts related to eating. Interventions may include cognitive behavioral therapy, family-based therapy, exposure therapy, and, in certain cases, pharmacotherapy. Hospitalization may be necessary for patients with severe malnutrition or medical complications. Nutritional rehabilitation, psychological interventions, and collaborative care involving a multidisciplinary team of healthcare professionals are essential for optimizing treatment outcomes and improving the quality of life for individuals with ARFID.</p>
      </sec>
      <sec id="article-164812.s2" sec-type="Etiology">
        <title>Etiology</title>
        <p>Despite increasing attention, ARFID's etiology and neurobiology remain poorly understood in the academic literature. The causes of ARFID are complex, encompassing genetic predispositions, environmental influences, neurobiological mechanisms, and psychosocial factors akin to other eating disorder etiologies.<xref ref-type="bibr" rid="article-164812.r4">[4]</xref>&#x000a0;ARFID shares several eating disorder characteristics (eg, anorexia nervosa), including restrictive eating, low body weight, and nutritional deficiencies.<xref ref-type="bibr" rid="article-164812.r5">[5]</xref>&#x000a0;Evidence also suggests a possible shared etiology between anorexia nervosa and ARFID, as patients with ARFID may be diagnosed with anorexia nervosa later.<xref ref-type="bibr" rid="article-164812.r6">[6]</xref></p>
        <p>A recent sizeable Swedish twin study has indicated a significant heritable component to ARFID, suggesting that genetic factors play an essential role in the development of the disorder. In this study, twins aged 6 to 12 years showed that the predisposition to ARFID was primarily due to additive genetic factors, with inherited factors contributing approximately 79% and unshared environmental factors accounting for an estimated 21%, indicating a robust hereditary influence.<xref ref-type="bibr" rid="article-164812.r7">[7]</xref>&#x000a0;These findings encourage further genetic research into the disorder.&#x000a0;Early childhood experiences, sensory sensitivities, and anxiety disorders may also contribute to the development of ARFID.<xref ref-type="bibr" rid="article-164812.r8">[8]</xref>&#x000a0;Neurobiological models propose that ARFID exhibits abnormalities in appetite regulation, sensory perception, and heightened fear system activation, which contribute to the emergence of comorbid anxiety disorders and the perpetuation of restrictive eating behaviors. Notably, ARFID encompasses a heterogeneous population influenced by biological and environmental factors in the development and persistence of their eating patterns.<xref ref-type="bibr" rid="article-164812.r9">[9]</xref><xref ref-type="bibr" rid="article-164812.r8">[8]</xref></p>
      </sec>
      <sec id="article-164812.s3" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Previous studies employing comparable diagnostic criteria have reported an ARFID prevalence in the general child population ranging from 0.35% to 3.2% and globally in adult populations from 0.3% to 3.1%.<xref ref-type="bibr" rid="article-164812.r10">[10]</xref><xref ref-type="bibr" rid="article-164812.r11">[11]</xref><xref ref-type="bibr" rid="article-164812.r12">[12]</xref><xref ref-type="bibr" rid="article-164812.r13">[13]</xref><xref ref-type="bibr" rid="article-164812.r14">[14]</xref><xref ref-type="bibr" rid="article-164812.r15">[15]</xref>&#x000a0;Some studies have shown males with ARFID have a higher prevalence than females, especially in pediatric populations.<xref ref-type="bibr" rid="article-164812.r16">[16]</xref><xref ref-type="bibr" rid="article-164812.r17">[17]</xref>&#x000a0;However, DSM-V indicates a more balanced sex distribution of ARFID compared to other eating disorders (eg, anorexia nervosa and bulimia nervosa), which predominantly affect females. Furthermore, according to some studies, a larger proportion of ARFID cases are represented by males than in other eating disorders. These findings highlight the necessity for gender-sensitive approaches in both diagnosis and treatment.<xref ref-type="bibr" rid="article-164812.r16">[16]</xref></p>
        <p>Moreover, ARFID commonly occurs with other comorbid conditions, particularly neurodevelopmental disorders, including autism spectrum disorder and attention-deficit/hyperactivity disorder (ADHD).<xref ref-type="bibr" rid="article-164812.r5">[5]</xref><xref ref-type="bibr" rid="article-164812.r16">[16]</xref><xref ref-type="bibr" rid="article-164812.r18">[18]</xref>&#x000a0;Learning disabilities, obsessive-compulsive disorders (OCD), and anxiety disorders also occur with ARFID more frequently than other eating disorders.<xref ref-type="bibr" rid="article-164812.r5">[5]</xref><xref ref-type="bibr" rid="article-164812.r17">[17]</xref><xref ref-type="bibr" rid="article-164812.r19">[19]</xref>&#x000a0;This association suggests that the underlying mechanism of ARFID may be related to broader neurodevelopmental and psychological processes. The worldwide prevalence of ARFID is unclear due to ambiguity in diagnostic definitions and operationalization; however, ARFID poses a significant clinical challenge due to the condition's diverse and often subtle presentations.<xref ref-type="bibr" rid="article-164812.r20">[20]</xref></p>
      </sec>
      <sec id="article-164812.s4" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>ARFID is associated with alterations in brain regions involved in reward, motivation, and the sensory processing of food.<xref ref-type="bibr" rid="article-164812.r8">[8]</xref>&#x000a0;For instance, the insula, an area that helps regulate internal body states and process sensory information, is critical in the pathophysiology of ARFID.<xref ref-type="bibr" rid="article-164812.r21">[21]</xref>&#x000a0;When exposed to food stimuli, individuals with ARFID may have atypical activation patterns in the insula, leading to aversive responses to certain textures, tastes, or food smells.&#x000a0;In addition, a recent study proposed that the pathophysiology of ARFID may be associated with the following 3 neurobiological hypotheses:</p>
        <list list-type="order">
          <list-item>
            <p>Individuals with sensory sensitivity may have an intensified perception of tastes, particularly bitter and sweet, which might classify them as "supertasters" due to a biological predisposition.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>A lack of interest in food observed in some with ARFID could be linked to reduced brain activity in appetite-regulating areas (eg, hypothalamus and insula), which affect hunger sensations and satiety.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>For patients with ARFID&#x000a0; stemming from fear of aversive consequences (eg, choking), an exaggerated fear response may be present, possibly triggered by overactive fear-related brain circuitry involving the amygdala and prefrontal cortex.<xref ref-type="bibr" rid="article-164812.r8">[8]</xref></p>
          </list-item>
        </list>
        <p>Research regarding ARFID is still emerging; the role of serotonin in sensory processing and anxiety suggests a potential mechanism through which neurotransmitter dysregulation could influence the disorder. Moreover, sensory processing issues, which are not exclusive to ARFID but are also present in other conditions (eg, autism), may be associated with abnormal serotonin function, further supporting the need to investigate serotonin's role in ARFID.<xref ref-type="bibr" rid="article-164812.r22">[22]</xref></p>
      </sec>
      <sec id="article-164812.s5" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>
<bold>Clinical History</bold>
</p>
        <p>ARFID is clinically diagnosed and comprises the patient's medical, nutritional, and psychological assessment. Evaluation for ARFID primarily entails gathering a thorough history, including the onset, duration, and extent of restrictive eating behaviors, any precipitating factors (eg, traumatic feeding experiences), and associated gastrointestinal complaints.&#x000a0;The DSM-V outlines the following 4 criteria for diagnosing ARFID:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Criterion A</bold>: An eating or feeding disturbance linked to significant weight loss, nutritional deficiency, reliance on enteral feeding or supplements, or a notable change in psychosocial functioning is present. The possible causes for this disruption outlined in the DSM-V-TR include low appetite, sensory issues with food, and fear-related avoidance of eating.<xref ref-type="bibr" rid="article-164812.r23">[23]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Criterion B</bold>: The interference with eating is not due to religious or cultural factors or lack of food availability.</p>
          </list-item>
          <list-item>
            <p><bold>Criterion C</bold>: The disturbance is not attributable to other eating disorders like anorexia nervosa or bulimia nervosa, as evidenced by the absence of body image concerns.</p>
          </list-item>
          <list-item>
            <p><bold>Criterion D</bold>: Other psychiatric or medical conditions are excluded as an etiology for the disturbance.<xref ref-type="bibr" rid="article-164812.r1">[1]</xref><xref ref-type="bibr" rid="article-164812.r2">[2]</xref><xref ref-type="bibr" rid="article-164812.r23">[23]</xref><xref ref-type="bibr" rid="article-164812.r24">[24]</xref></p>
          </list-item>
        </list>
        <p>Adding to the diagnostic complexity, ARFID can manifest differently in individuals, with an array of symptoms across the 3 major drivers of the disorder.<xref ref-type="bibr" rid="article-164812.r3">[3]</xref>&#x000a0;Individuals with ARFID may display a persistent disinterest in eating or food, potentially leading to significant weight loss or an inability to meet nutritional needs adequately. While some patients with ARFID may have low body weight, the disorder can affect individuals of any weight.<xref ref-type="bibr" rid="article-164812.r6">[6]</xref>&#x000a0;Individuals with ARFID frequently have a reduced appetite or adopt behaviors restricting food intake, including eating small bites, prolonged meal times, or excessive chewing.<xref ref-type="bibr" rid="article-164812.r5">[5]</xref>&#x000a0;In female patients, clinicians should also obtain a menstrual history, which may identify primary amenorrhea in premenarchal females and secondary amenorrhea in postmenarchal females secondary to malnutrition and significant weight loss.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref>&#x000a0;Furthermore, ascertaining the presence of mental health comorbidities or underlying medical conditions is imperative. Psychiatric comorbidities are frequently observed in those with ARFID, particularly anxiety disorders, including generalized anxiety disorder.<xref ref-type="bibr" rid="article-164812.r6">[6]</xref><xref ref-type="bibr" rid="article-164812.r24">[24]</xref><xref ref-type="bibr" rid="article-164812.r25">[25]</xref>&#x000a0;ARFID is also commonly associated with neurodevelopment disorders (eg, autism spectrum disorder and ADHD).<xref ref-type="bibr" rid="article-164812.r26">[26]</xref><xref ref-type="bibr" rid="article-164812.r27">[27]</xref>&#x000a0;Additionally, various conditions may also present with appetite loss or weight reduction, including tumors or endocrine disorders (eg, type 1 diabetes, hyperthyroidism, or Addison disease), infections, gastrointestinal ailments (eg, Crohn disease, ulcerative colitis, or celiac disease), and swallowing difficulties (eg, achalasia or tonsillar hypertrophy). Therefore, differential diagnoses should be considered during the evaluation process.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref>&#x000a0;</p>
        <p>As part of a dietary history, a patient's eating habits should be documented, including past and current eating patterns, the types and amounts of food and drinks consumed, typical eating locations, preferred cooking methods, food brands, and meal sources (eg, specific restaurants or homemade meals). Additionally, clinicians should identify individual dietary preferences and aversions regarding textures, flavors, aromas, and food appearances.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref>&#x000a0;Weight loss, failure to achieve expected growth, or reliance on nutritional supplements should also be noted.&#x000a0;Dietary preferences characteristically revolve around aversions to specific food tastes, textures, colors, or smells rather than concerns about body shape or weight.<xref ref-type="bibr" rid="article-164812.r29">[29]</xref>&#x000a0;Symptoms may include abdominal pain, nausea, or other gastrointestinal discomfort associated with eating, as well as intense fears of choking, nausea, vomiting, allergic reactions, or illness.<xref ref-type="bibr" rid="article-164812.r5">[5]</xref><xref ref-type="bibr" rid="article-164812.r3">[3]</xref><xref ref-type="bibr" rid="article-164812.r30">[30]</xref>&#x000a0;Symptom onset may be sudden following a traumatic food-related incident, often accompanied by an anxiety disorder.<xref ref-type="bibr" rid="article-164812.r5">[5]</xref>&#x000a0;Mealtimes often become stressful for families, and patients may avoid social gatherings involving food. Caregivers may notice a consistent pattern where the individual exhibits selectivity in their food preferences, often opting for a narrow variety of foods.<xref ref-type="bibr" rid="article-164812.r5">[5]</xref>&#x000a0;Despite their nutritional impact, these behaviors are not driven by an expressed desire to lose weight but rather by the distressing experience associated with eating.&#x000a0;</p>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>In addition to assessing an individual's anxiety or phobic responses to eating, a full review of systems and a thorough physical examination are essential. Reviewing growth curves, including weight, height, and body mass index (BMI), is crucial in determining the patient's condition. Objective findings on physical examination may reveal signs consistent with malnutrition, including cachexia, muscle wasting, or micronutrient deficiencies (eg, pallor from anemia, petechiae, or vitamin C deficiency ecchymosis).&#x000a0;In contrast to anorexia nervosa, ARFID does not involve body image disturbances. However, patients may suffer from significant nutritional deficiencies and experience physical effects, including fatigue, lack of concentration, and growth delay in children and adolescents&#x000a0;due to inadequate food intake. Consequently, patients with ARFID may also develop anemia, bradycardia, or muscle-wasting conditions. Sexual maturity should also be assessed to determine the puberty stage and identify growth abnormalities.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref>&#x000a0;Vital sign abnormalities may include bradycardia, hypotension, and orthostatic changes. In pediatric patients, body mass index (BMI) measurements and growth parameters should be carefully assessed against standard growth charts to identify deviations from expected growth trajectories. A gastrointestinal examination may reveal signs of delayed gastric emptying or constipation secondary to low dietary fiber intake.<xref ref-type="bibr" rid="article-164812.r1">[1]</xref></p>
      </sec>
      <sec id="article-164812.s6" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>
<bold>Diagnostic Studies</bold>
</p>
        <p>While laboratory tests are not diagnostic for ARFID, they are necessary to assess the nutritional status and identify deficiencies or metabolic disturbances. A complete blood count, a comprehensive metabolic panel with liver function tests, thyroid function, and vitamin and mineral levels are frequently performed, particularly in cases where malnutrition is suspected.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref>&#x000a0;In addition, various laboratory tests to exclude differential diagnoses may be considered, including erythrocyte sedimentation rate, luteinizing hormone, follicle-stimulating hormone, estradiol, testosterone, urinalysis, and Celiac disease screening with tissue transglutaminase antibodies and total IgA.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref>&#x000a0;These studies help to evaluate the hydration status, check for inflammatory conditions or malignancies, and assess hormone levels and nutritional deficiencies that may result from malnutrition.&#x000a0;Radiographic imaging is not typically necessary unless specific gastrointestinal symptoms (eg, chronic constipation or suspicion of gastrointestinal obstruction) warrant further investigation through diagnostic imaging studies. Other tests, such as bone density scans, may be considered to assess the impact of chronic malnutrition on bone health, especially in longstanding cases.&#x000a0;</p>
        <p>
<bold>Psychological </bold>
<bold>E</bold>
<bold>valuation</bold>
</p>
        <p>In the last decade, assessments have emerged for screening, evaluating, and tracking treatment outcomes for ARFID.<xref ref-type="bibr" rid="article-164812.r23">[23]</xref>&#x000a0;Psychological evaluation for ARFID includes structured office-based interviews and self-reporting measures. Office-based screens that may be utilized for ARFID evaluation include the&#x000a0;Eating disorder assessment for&#x000a0;DSM-5&#x000a0;(EDA-5), structured clinical interview for&#x000a0;DSM-5 (SCID-5), eating disorder examination (EDE) ARFID module, and pica, ARFID, and rumination disorder interview (PARDI assess ARFID). Each of these screening methods has positive and negative features.</p>
        <p>Self-reporting screens, including the food phobia scale (FNS), nine-item ARFID screen (NIAS), pica, ARFID, and rumination disorder &#x02013; ARFID questionnaire (PARDI-AR-Q), and the eating disorder examination questionnaire (EDE-Q) may also be utilized in the evaluation of ARFID. These self-reporting screens measure different aspects of ARFID psychopathology. While these measures offer valuable insights, they have limitations and require validation with office-based screening. Combining structured clinical interviews with self-reports provides a more thorough assessment, aiding diagnosis and treatment monitoring.</p>
        <p>
<bold>Additional E</bold>
<bold>valuation</bold>
</p>
        <p>Further evaluation or consultation services may be indicated following clinical assessment with growth trajectories and laboratory evaluation.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref>&#x000a0;Consultation with a dietitian for nutritional assessment is recommended in patients with ARFID. In cases where comorbid psychological conditions are suspected, a mental health evaluation is also essential. Patients who exhibit slow eating may need to evaluate their chewing and swallowing abilities; patients with growth concerns may be referred to an endocrinologist, while those with gastrointestinal symptoms may require a referral to a gastroenterologist.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref></p>
      </sec>
      <sec id="article-164812.s7" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Due to the recent emergence of the ARFID diagnosis, limited evidence supporting treatment strategies for this condition exists, and consensus guidelines have yet to be established. Cognitive behavioral therapy, family-based therapy, and pharmacotherapy are the most common treatment modalities suggested in the existing literature.<xref ref-type="bibr" rid="article-164812.r31">[31]</xref>&#x000a0;To date, no studies have evaluated the effectiveness of ARFID-specific treatment through randomized, fully powered, controlled trials.<xref ref-type="bibr" rid="article-164812.r23">[23]</xref>&#x000a0;The treatment goals for individuals diagnosed with ARFID should consist of the following key components:</p>
        <list list-type="bullet">
          <list-item>
            <p>Attain medical stability, addressing immediate health concerns and stabilizing comorbid medical conditions.</p>
          </list-item>
          <list-item>
            <p>Determine the most appropriate level of care, whether outpatient or inpatient, based on individual needs and severity of symptoms.</p>
          </list-item>
          <list-item>
            <p>Provide adequate nutrition and monitor progress regularly to restore weight to a healthy range and ensure proper growth.</p>
          </list-item>
          <list-item>
            <p>Enhance nutritional health by expanding the variety and quantity of foods consumed and addressing any nutrient deficiencies.</p>
          </list-item>
          <list-item>
            <p>Address and manage any fears or discomforts related to eating, which may involve exposure therapy or other behavioral interventions.</p>
          </list-item>
          <list-item>
            <p>Promote the enjoyment of eating by identifying enjoyable foods and developing a positive relationship with food.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Pharmacological Management</bold>
</p>
        <p>Pharmacotherapy is not the primary approach for treating ARFID but may be applicable in certain cases.<xref ref-type="bibr" rid="article-164812.r32">[32]</xref>&#x000a0;For instance, mirtazapine has been cited due to its appetite-stimulating and anxiolytic properties. Medications, including cyproheptadine, selective serotonin reuptake inhibitors (SSRIs), or atypical antipsychotics (eg, olanzapine), are often used to address associated symptoms rather than ARFID itself. Cyproheptadine, in particular, is an effective off-label option for ARFID as this medication enhances appetite; consideration as a potential treatment for malnourished adults and children, including those diagnosed with ARFID, is warranted.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref><xref ref-type="bibr" rid="article-164812.r31">[31]</xref>&#x000a0;</p>
        <p>Olanzapine has also been used off-label to help reduce anxiety, cognitive rigidity, and food-related beliefs that can contribute to ARFID symptoms; in some patients, weight gain may be promoted.<xref ref-type="bibr" rid="article-164812.r33">[33]</xref><xref ref-type="bibr" rid="article-164812.r34">[34]</xref>&#x000a0;A case study reported that the addition of low-dose olanzapine to ARFID treatment helped reduce anxiety and depression in a patient.<xref ref-type="bibr" rid="article-164812.r35">[35]</xref>&#x000a0;Another case series found that using olanzapine, along with the antidepressant fluoxetine, helped 2 adolescent twins with ARFID reach their target weights within 3 to 6 months of starting treatment.<xref ref-type="bibr" rid="article-164812.r34">[34]</xref>&#x000a0;However, the supportive evidence for ARFID treatment with olanzapine is still limited, with no randomized controlled trials demonstrating efficacy. Therefore, olanzapine remains an off-label, experimental treatment.</p>
        <p>
<bold>Inpatient Management</bold>
</p>
        <p>In cases of ARFID, hospitalization may be necessary to address poor nutritional intake or dangerously low weight and to restore healthy eating behaviors.<xref ref-type="bibr" rid="article-164812.r36">[36]</xref> Studies primarily focused on adolescent or mixed-age groups have examined the hospital course of ARFID. Some findings suggest that adolescents and young adults with ARFID present with similar body mass index (BMI) or percent target weight upon admission compared to patients with anorexia nervosa.<xref ref-type="bibr" rid="article-164812.r37">[37]</xref> However, discrepancies among study findings have been noted.<xref ref-type="bibr" rid="article-164812.r38">[38]</xref><xref ref-type="bibr" rid="article-164812.r30">[30]</xref> Length of hospital stay varies across studies, with some reporting longer stays for ARFID patients and others finding no significant difference. Furthermore, weight gain rates during hospitalization also vary, with some studies indicating slower weight gain in ARFID compared to anorexia nervosa patients, though weight outcomes at discharge appear comparable. Longer-term follow-up studies suggest that adolescents with ARFID may have higher recovery rates compared to those with anorexia nervosa, although further research is needed to confirm these findings.</p>
        <p>The American Psychiatric Association recommends hospitalization be considered in patients with ARFID if the following clinical factors are present:</p>
        <list list-type="bullet">
          <list-item>
            <p>BMI &#x0003c;75% of the median for age and gender</p>
          </list-item>
          <list-item>
            <p>Dehydration symptoms</p>
          </list-item>
          <list-item>
            <p>Abnormal electrolyte levels (eg, hypokalemia, hyponatremia, or hypophosphatemia)</p>
          </list-item>
          <list-item>
            <p>ECG irregularities, including prolonged QTc interval or significant bradycardia</p>
          </list-item>
          <list-item>
            <p>Physiological instability signs, such as:</p>
          </list-item>
          <list-item>
            <p>daytime bradycardia (&#x0003c;50 bpm) or nighttime bradycardia(&#x0003c;45 bpm)</p>
          </list-item>
          <list-item>
            <p>Hypotension (&#x0003c;90/45 mm Hg)</p>
          </list-item>
          <list-item>
            <p>Hypothermia (&#x0003c;96&#x000a0;&#x000b0;F (35.6 &#x000b0;C)</p>
          </list-item>
          <list-item>
            <p>Significant orthostatic pulse changes (increase in heart rate by &#x0003e;30 bpm for adults older than 19 or &#x0003e;40 bpm for adolescents younger than 19, or a sustained blood pressure decrease of &#x0003e;20 mm Hg systolic or &#x0003e;10 mm Hg diastolic)&#x000a0;<xref ref-type="bibr" rid="article-164812.r39">[39]</xref><xref ref-type="bibr" rid="article-164812.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>Stunted growth and developmental progress</p>
          </list-item>
          <list-item>
            <p>Unsuccessful outpatient treatment attempts</p>
          </list-item>
          <list-item>
            <p>Food refusal</p>
          </list-item>
          <list-item>
            <p>Immediate malnutrition-related medical complications like fainting, seizures, cardiac failure, or pancreatitis.</p>
          </list-item>
          <list-item>
            <p>Presence of a concurrent psychiatric or medical condition complicating or hindering effective outpatient care, such as severe depression, suicidal ideation, obsessive-compulsive disorder, psychosis, or type 1 diabetes.<xref ref-type="bibr" rid="article-164812.r41">[41]</xref><xref ref-type="bibr" rid="article-164812.r42">[42]</xref><xref ref-type="bibr" rid="article-164812.r43">[43]</xref><xref ref-type="bibr" rid="article-164812.r44">[44]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Nutritional Management</bold>
</p>
        <p>Nutritional rehabilitation, which focuses on establishing regular eating patterns and reintroducing a broader range of foods, is the cornerstone of ARFID management. Nutritional management often requires the expertise of dietitians specializing in eating disorders. Close monitoring of growth and development, particularly in pediatric populations, is crucial.&#x000a0;The primary management of ARFID focuses on gradually improving nutritional adequacy, balanced eating habits, and weight gain with the help of a registered dietitian nutritionist (RDN) and the patient's family.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref>&#x000a0;Together, they work to increase the patient's overall food intake, introduce new foods gradually, and help the patient make significant progress toward better nutritional health.</p>
        <p>In severe cases, hospitalization may be necessary to address nutritional deficiencies and ensure safety. To avoid adverse effects on taste, hunger, mood, and energy, ensuring the timely replenishment of essential nutrients (eg, vitamin B12, vitamin C, iron, zinc, and folate) is vital. Nasogastric tube feedings may also be necessary to counteract malnutrition in severe cases where patients consume minimal food and drink. As the patient's overall intake improves, whether in a hospital or outpatient setting, the foods and beverages they previously enjoyed will gradually be reintroduced into their diet, with the ultimate goal of resuming their typical diet over time. Consequently, the nutritional treatment for ARFID aims to enhance the overall nutritional status, eating habits, and social functioning regarding food.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref></p>
        <p>
<bold>Psychological Management</bold>
</p>
        <p>Psychotherapeutic interventions form a significant part of the treatment landscape for ARFID. Cognitive-behavioral therapy tailored for ARFID, family-based therapy, and exposure therapies have shown efficacy. These therapies aim to reduce meal-related anxiety, modify disruptive eating patterns, and address distorted beliefs about food. These 3 psychological therapies primarily revolve around the following evidence-based approaches for ARFID:</p>
        <list list-type="order">
          <list-item>
            <p>Family-based treatment for ARFID: This approach targets specific aspects of ARFID based on the subtype, typically focusing on consistent and necessary eating habits and gradual weight gain. Therapists aim to enhance parents' confidence in modifying feeding strategies to decrease restrictive eating patterns.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref><xref ref-type="bibr" rid="article-164812.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Cognitive behavior therapy for ARFID: This therapy addresses nutritional deficiency, increases exposure to new foods, and reduces negative feelings and expectations about food and eating.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref><xref ref-type="bibr" rid="article-164812.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p>Supportive parenting for anxious childhood emotions for ARFID: A specific mental health treatment designed for children with anxiety disorders and OCD. With this approach, clinicians concentrate exclusively on working with caregivers to address caregiver accommodation to modify caregivers' behaviors and reactions to their child's symptoms.<xref ref-type="bibr" rid="article-164812.r28">[28]</xref>&#x000a0;</p>
          </list-item>
        </list>
        <p>Psychological management often involves a combination of outpatient therapy sessions, intensive outpatient programs, and even partial hospitalization, depending on the severity of the condition. National and international guidelines advocate for a personalized approach to care, considering each patient's unique needs with ARFID. Collaborative care models are considered best practices, where an interprofessional team of healthcare professionals works together. Engaging a team of healthcare professionals with diverse specializations is recommended, including a primary care clinician, a mental health specialist, a dietician, a gastroenterologist, an occupational therapist, and a speech therapist, based on the patient's specific requirements.<xref ref-type="bibr" rid="article-164812.r31">[31]</xref></p>
      </sec>
      <sec id="article-164812.s8" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Several diagnoses may present with distinct clinical features that mimic ARFID and warrant specific clinical evaluations. Therefore, a careful and thorough assessment is necessary to distinguish ARFID from other medical, psychological, or psychiatric conditions. The differential diagnoses for ARFID that should also be considered include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anorexia nervosa</p>
          </list-item>
          <list-item>
            <p>Bulimia nervosa</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Eosinophilic esophagitis</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Food allergies</p>
          </list-item>
          <list-item>
            <p>Celiac disease</p>
          </list-item>
          <list-item>
            <p>Chronic idiopathic constipation</p>
          </list-item>
          <list-item>
            <p>Pica</p>
          </list-item>
          <list-item>
            <p>Rumination disorder</p>
          </list-item>
          <list-item>
            <p>Autism spectrum disorders (where food selectivity is common)</p>
          </list-item>
          <list-item>
            <p>Anxiety disorders</p>
          </list-item>
          <list-item>
            <p>Major depressive disorder (with changes in appetite or weight)</p>
          </list-item>
          <list-item>
            <p>Social phobia (may affect eating in public settings)</p>
          </list-item>
          <list-item>
            <p>OCD</p>
          </list-item>
          <list-item>
            <p>Post-traumatic stress disorder, following a traumatic event related to eating or food</p>
          </list-item>
          <list-item>
            <p>ADHD, when associated with impulsivity affecting eating behaviors</p>
          </list-item>
          <list-item>
            <p>Neurodevelopmental disorders with sensory sensitivities affecting feeding</p>
          </list-item>
          <list-item>
            <p>Structural anomalies of the oropharynx or gastrointestinal tract affecting intake</p>
          </list-item>
          <list-item>
            <p>Endocrine disorders like Addison disease or hypothyroidism affect appetite</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-164812.s9" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Evidence regarding the different dimensions of ARFID is lacking. Moreover, the existing data are insufficient to determine the course of the illness and prognosis for patients diagnosed with ARFID.<xref ref-type="bibr" rid="article-164812.r45">[45]</xref>&#x000a0;The prognosis for ARFID can vary depending on several factors, including age of onset, duration of illness, and comorbidities. Early diagnosis and intervention are critical for successful treatment, but unfortunately, access to mental health services and treatment options is currently limited. In addition, chronic cases can lead to severe nutritional deficits and psychosocial impairments. A thorough biopsychosocial approach is necessary for effective treatment. Increasing awareness and targeted interventions will lead to better outcomes and improved access to care.<xref ref-type="bibr" rid="article-164812.r46">[46]</xref><xref ref-type="bibr" rid="article-164812.r47">[47]</xref><xref ref-type="bibr" rid="article-164812.r48">[48]</xref>&#x000a0;Ongoing research is crucial to understand long-term outcomes better.</p>
      </sec>
      <sec id="article-164812.s10" sec-type="Complications">
        <title>Complications</title>
        <p>The medical complications arising from ARFID can closely mirror those of anorexia nervosa, mainly due to malnutrition and nutritional deficiencies. The condition can lead to various medical, psychological, and social complications. Complications of ARFID can be extensive, affecting various body systems due to persistent nutritional deficits.<xref ref-type="bibr" rid="article-164812.r24">[24]</xref><xref ref-type="bibr" rid="article-164812.r49">[49]</xref><xref ref-type="bibr" rid="article-164812.r50">[50]</xref><xref ref-type="bibr" rid="article-164812.r51">[51]</xref><xref ref-type="bibr" rid="article-164812.r50">[50]</xref></p>
        <p>
<bold>Cardiopulmonary Complications</bold>
</p>
        <p>Medical complications specific to the cardiopulmonary system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bradycardia</p>
          </list-item>
          <list-item>
            <p>Hypotension</p>
          </list-item>
          <list-item>
            <p>Cardiac arrhythmias</p>
          </list-item>
          <list-item>
            <p>Refeeding syndrome</p>
          </list-item>
          <list-item>
            <p>Reduced cardiac mass</p>
          </list-item>
          <list-item>
            <p>Mitral valve prolapse</p>
          </list-item>
          <list-item>
            <p>Orthostatic hypotension</p>
          </list-item>
          <list-item>
            <p>Pericardial effusion</p>
          </list-item>
          <list-item>
            <p>Cardiomyopathy</p>
          </list-item>
          <list-item>
            <p>Heart failure</p>
          </list-item>
          <list-item>
            <p>Pulmonary edema associated with refeeding syndrome</p>
          </list-item>
        </list>
        <p>
<bold>Renal Complications</bold>
</p>
        <p>Complications affecting the renal system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Acute kidney injury</p>
          </list-item>
          <list-item>
            <p>Electrolyte imbalances (eg, hypokalemia, hyponatremia, hypocalcemia, hypomagnesemia, and hypophosphatemia)</p>
          </list-item>
          <list-item>
            <p>Chronic kidney disease</p>
          </list-item>
          <list-item>
            <p>Proteinuria</p>
          </list-item>
          <list-item>
            <p>Renal calculi</p>
          </list-item>
        </list>
        <p>
<bold>Gastrointestinal Complications</bold>
</p>
        <p>Medical complications specific to the gastrointestinal system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Constipation</p>
          </list-item>
          <list-item>
            <p>Gastroparesis</p>
          </list-item>
          <list-item>
            <p>Gastroesophageal reflux disease</p>
          </list-item>
          <list-item>
            <p>Dysphagia</p>
          </list-item>
          <list-item>
            <p>Bloating and gas</p>
          </list-item>
          <list-item>
            <p>Irritable bowel syndrome</p>
          </list-item>
          <list-item>
            <p>Functional dyspepsia</p>
          </list-item>
          <list-item>
            <p>Peptic ulcers</p>
          </list-item>
          <list-item>
            <p>Abnormal liver function</p>
          </list-item>
        </list>
        <p>
<bold>Endocrinological and Reproductive Complications</bold>
</p>
        <p>The following reproductive and hormonal complications may also develop:</p>
        <list list-type="bullet">
          <list-item>
            <p>Growth hormone dysregulation</p>
          </list-item>
          <list-item>
            <p>Hypothalamic amenorrhea</p>
          </list-item>
          <list-item>
            <p>Thyroid function abnormalities (eg, euthyroid sick syndrome, hypothyroidism, low metabolic rate)</p>
          </list-item>
          <list-item>
            <p>Adrenal insufficiency</p>
          </list-item>
          <list-item>
            <p>Delayed puberty</p>
          </list-item>
          <list-item>
            <p>Bone metabolism disturbances (eg, decreased bone mineral density and increased fracture risk)</p>
          </list-item>
          <list-item>
            <p>Hypoglycemia</p>
          </list-item>
          <list-item>
            <p>Leptin and ghrelin imbalance</p>
          </list-item>
          <list-item>
            <p>Pancreatic function impairment</p>
          </list-item>
          <list-item>
            <p>Low libido</p>
          </list-item>
          <list-item>
            <p>Infertility</p>
          </list-item>
          <list-item>
            <p>Pregnancy complications</p>
          </list-item>
          <list-item>
            <p>Erectile dysfunction</p>
          </list-item>
        </list>
        <p>
<bold>Musculoskeletal Complications</bold>
</p>
        <p>Complications affecting muscle and skeletal systems include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Decreased muscle mass</p>
          </list-item>
          <list-item>
            <p>Osteopenia and osteoporosis</p>
          </list-item>
          <list-item>
            <p>Growth retardation</p>
          </list-item>
          <list-item>
            <p>Rickets</p>
          </list-item>
          <list-item>
            <p>Muscle weakness</p>
          </list-item>
          <list-item>
            <p>Delayed recovery from injury</p>
          </list-item>
        </list>
        <p>
<bold>Dermatological Complications</bold>
</p>
        <p>The following skin disorders may also develop:</p>
        <list list-type="bullet">
          <list-item>
            <p>Dry, flaky skin</p>
          </list-item>
          <list-item>
            <p>Bruising</p>
          </list-item>
          <list-item>
            <p>Hair thinning or loss</p>
          </list-item>
          <list-item>
            <p>Eczema or dermatitis</p>
          </list-item>
          <list-item>
            <p>Pallor</p>
          </list-item>
          <list-item>
            <p>Acrodermatitis</p>
          </list-item>
          <list-item>
            <p>Edema</p>
          </list-item>
        </list>
        <p>
<bold>Hematological Complications</bold>
</p>
        <p>Complications affecting the hematologic system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Anemia (eg, iron, vitamin B12, or folate deficiencies)</p>
          </list-item>
          <list-item>
            <p>Leukopenia</p>
          </list-item>
          <list-item>
            <p>Thrombocytopenia</p>
          </list-item>
          <list-item>
            <p>Coagulation disorders</p>
          </list-item>
        </list>
        <p>
<bold>Immunological Complications</bold>
</p>
        <p>Complications affecting the immunologic system include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Increased infection susceptibility</p>
          </list-item>
          <list-item>
            <p>Impaired wound healing</p>
          </list-item>
          <list-item>
            <p>Reduce efficacy of vaccinations (due to weakened immune system)</p>
          </list-item>
          <list-item>
            <p>Chronic inflammation</p>
          </list-item>
          <list-item>
            <p>Atrophy of lymphoidtTissues</p>
          </list-item>
        </list>
        <p>
<bold>Neuropsychological Complications</bold>
</p>
        <p>Several neurologic and psychologic conditions may develop due to ARFID, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cognitive Impairments (including memory, attention, and executive function)</p>
          </list-item>
          <list-item>
            <p>Neuropathy</p>
          </list-item>
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Developmental delays</p>
          </list-item>
          <list-item>
            <p>Mood disorders</p>
          </list-item>
          <list-item>
            <p>Concentration and learning difficulties</p>
          </list-item>
          <list-item>
            <p>Headaches</p>
          </list-item>
          <list-item>
            <p>Reduced brain volume</p>
          </list-item>
          <list-item>
            <p>Sleep disturbances</p>
          </list-item>
          <list-item>
            <p>Syncope</p>
          </list-item>
          <list-item>
            <p>Eating disorders</p>
          </list-item>
          <list-item>
            <p>Personality changes (eg, irritability and emotional lability)</p>
          </list-item>
          <list-item>
            <p>Social isolation</p>
          </list-item>
          <list-item>
            <p>Impaired social development and decreased overall quality of life</p>
          </list-item>
          <list-item>
            <p>Strained family relationships and increased stress</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-164812.s11" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Management of ARFID involves implementing strategies to prevent the development or worsening of the disorder and educating individuals about its nature, symptoms, and management. These efforts aim to raise awareness about ARFID risk factors, including extreme pickiness or food avoidance behaviors in children, and provide support to address these issues early on to prevent the disorder's progression. Patient education initiatives may include information sessions, pamphlets, or online resources that outline ARFID's symptoms, potential consequences, and available treatment options. Additionally, healthcare clinicians play a crucial role in educating patients and their families about ARFID, its impact on physical and mental health, and the importance of seeking timely intervention and support.&#x000a0;</p>
      </sec>
      <sec id="article-164812.s12" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>ARFID poses substantial risks to both physical and mental health, potentially resulting in malnutrition, growth impairments, and the necessity for nutritional intervention. Patients may rely on tube feeding or dietary supplements, significantly impacting their overall quality of life. Moreover, the disorder can precipitate anxiety and other comorbid mental health conditions. Overlooking the psychological aspects of ARFID treatment should be avoided. Addressing anxiety and sensory aversions related to eating is equally paramount to enhancing food consumption. Healthcare professionals should be equipped to evaluate the influence of ARFID on the patient's quality of life and psychosocial well-being.<xref ref-type="bibr" rid="article-164812.r52">[52]</xref>&#x000a0;Despite its growing importance, ARFID is frequently underdiagnosed or inadequately treated within clinical settings. Although the standard care protocol typically entails a multidisciplinary team of specialized healthcare clinicians, the therapeutic approach for this disorder encounters specific gaps due to the lack of interventional trials and variations in methodologies across existing studies.</p>
        <p>Preventive measures should focus on early identification of at-risk individuals, particularly children displaying pronounced pickiness or food avoidance behaviors that impede growth and development, and offer support to prevent the disorder's progression. A systematic review of current practices is advantageous for understanding and managing ARFID; however, standardized guidelines and further research are crucial.&#x000a0;Moreover, the epidemiology of ARFID demonstrates significant disparities in sex and gender-related matters, distinguishing it as a distinct entity within eating disorders. Gender nuances in ARFID extend beyond mere prevalence, affecting presentation, risk factors, and treatment engagement. For example, societal expectations and gender norms may influence the acknowledgment and reporting of eating difficulties, particularly among males, who might be less inclined to seek assistance due to stigma or misconceptions about eating disorders primarily afflicting females. This gender gap underscores the importance of fostering awareness and comprehension among healthcare practitioners and the general public to ensure equal access to care for all individuals affected by ARFID, regardless of their sex or gender identity.</p>
      </sec>
      <sec id="article-164812.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>To enhance patient-centered care, outcomes, patient safety, and team performance related to ARFID, an interprofessional team comprising physicians, advanced practitioners, nurses, pharmacists, and other health professionals collaborates closely. They collectively address the distinct challenges presented by ARFID, characterized by a persistent lack of interest in eating, selective food avoidance, and resultant weight loss or nutritional deficiencies. This team approach ensures comprehensive treatment, with dietitians assessing nutritional status and devising tailored meal plans, speech-language pathologists targeting oral-motor and sensory processing difficulties, and occupational therapists expanding food repertoires and improving mealtime behaviors. Mental health professionals provide cognitive-behavioral therapy and exposure therapy to address psychological factors maintaining ARFID.</p>
        <p>The individualized treatment approach considers patient age, condition, and accompanying symptoms, with regular dietary screening in pediatric follow-up essential for addressing nutritional and psychological effects. Through coordinated care and specialized expertise, the interprofessional team ensures thorough assessment and multidisciplinary treatment, optimizing patient outcomes and improving the quality of life for individuals with ARFID.</p>
      </sec>
      <sec id="article-164812.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=164812&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=164812">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/eating-disorders/avoidant-restrictive-food-intake-disorder-arfid-selective-eating-disorder/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=164812">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/164812/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=164812">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-164812.s15">
        <title>References</title>
        <ref id="article-164812.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Archibald</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bryant-Waugh</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Current evidence for avoidant restrictive food intake disorder: Implications for clinical practice and future directions.</article-title>
            <source>JCPP Adv</source>
            <year>2023</year>
            <month>Jun</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>e12160</fpage>
            <pub-id pub-id-type="pmid">37753149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sanchez-Cerezo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nagularaj</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Gledhill</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nicholls</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>What do we know about the epidemiology of avoidant/restrictive food intake disorder in children and adolescents? A systematic review of the literature.</article-title>
            <source>Eur Eat Disord Rev</source>
            <year>2023</year>
            <month>Mar</month>
            <volume>31</volume>
            <issue>2</issue>
            <fpage>226</fpage>
            <page-range>226-246</page-range>
            <pub-id pub-id-type="pmid">36527163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Watts</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Archibald</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hembry</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Howard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kelly</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Loomes</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Markham</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Munuve</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Oros</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siddall</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rhind</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Uddin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ahmad</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Bryant-Waugh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>H&#x000fc;bel</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>The clinical presentation of avoidant restrictive food intake disorder in children and adolescents is largely independent of sex, autism spectrum disorder and anxiety traits.</article-title>
            <source>EClinicalMedicine</source>
            <year>2023</year>
            <month>Sep</month>
            <volume>63</volume>
            <fpage>102190</fpage>
            <pub-id pub-id-type="pmid">37680940</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bulik</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Exploring the gene-environment nexus in eating disorders.</article-title>
            <source>J Psychiatry Neurosci</source>
            <year>2005</year>
            <month>Sep</month>
            <volume>30</volume>
            <issue>5</issue>
            <fpage>335</fpage>
            <page-range>335-9</page-range>
            <pub-id pub-id-type="pmid">16151538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Dinkler</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Kennedy</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bulik</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>How genetic analysis may contribute to the understanding of avoidant/restrictive food intake disorder (ARFID).</article-title>
            <source>J Eat Disord</source>
            <year>2022</year>
            <month>Apr</month>
            <day>15</day>
            <volume>10</volume>
            <issue>1</issue>
            <fpage>53</fpage>
            <pub-id pub-id-type="pmid">35428338</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norris</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Spettigue</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Henderson</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Exploring avoidant/restrictive food intake disorder in eating disordered patients: a descriptive study.</article-title>
            <source>Int J Eat Disord</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>47</volume>
            <issue>5</issue>
            <fpage>495</fpage>
            <page-range>495-9</page-range>
            <pub-id pub-id-type="pmid">24343807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dinkler</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Wronski</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Lichtenstein</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lundstr&#x000f6;m</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Larsson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bulik</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Etiology of the Broad Avoidant Restrictive Food Intake Disorder Phenotype in Swedish Twins Aged 6 to 12 Years.</article-title>
            <source>JAMA Psychiatry</source>
            <year>2023</year>
            <month>Mar</month>
            <day>01</day>
            <volume>80</volume>
            <issue>3</issue>
            <fpage>260</fpage>
            <page-range>260-269</page-range>
            <pub-id pub-id-type="pmid">36723946</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Deckersbach</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>KT</given-names>
              </name>
            </person-group>
            <article-title>Avoidant/Restrictive Food Intake Disorder: a Three-Dimensional Model of Neurobiology with Implications for Etiology and Treatment.</article-title>
            <source>Curr Psychiatry Rep</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>19</volume>
            <issue>8</issue>
            <fpage>54</fpage>
            <pub-id pub-id-type="pmid">28714048</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Van Buuren</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fleming</surname>
                <given-names>CAK</given-names>
              </name>
              <name>
                <surname>Hay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bussey</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Trompeter</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lonergan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mitchison</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Correction: The prevalence and burden of avoidant/restrictive food intake disorder (ARFID) in a general adolescent population.</article-title>
            <source>J Eat Disord</source>
            <year>2023</year>
            <month>Aug</month>
            <day>29</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>148</fpage>
            <pub-id pub-id-type="pmid">37644590</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zickgraf</surname>
                <given-names>HF</given-names>
              </name>
              <name>
                <surname>Franklin</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Rozin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Adult picky eaters with symptoms of avoidant/restrictive food intake disorder: comparable distress and comorbidity but different eating behaviors compared to those with disordered eating symptoms.</article-title>
            <source>J Eat Disord</source>
            <year>2016</year>
            <volume>4</volume>
            <fpage>26</fpage>
            <pub-id pub-id-type="pmid">27800160</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hay</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mitchison</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Collado</surname>
                <given-names>AEL</given-names>
              </name>
              <name>
                <surname>Gonz&#x000e1;lez-Chica</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Stocks</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Touyz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Burden and health-related quality of life of eating disorders, including Avoidant/Restrictive Food Intake Disorder (ARFID), in the Australian population.</article-title>
            <source>J Eat Disord</source>
            <year>2017</year>
            <volume>5</volume>
            <fpage>21</fpage>
            <pub-id pub-id-type="pmid">28680630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schmidt</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Adan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>B&#x000f6;hm</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>IC</given-names>
              </name>
              <name>
                <surname>Dingemans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ehrlich</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elzakkers</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Favaro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Giel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Harrison</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Himmerich</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hoek</surname>
                <given-names>HW</given-names>
              </name>
              <name>
                <surname>Herpertz-Dahlmann</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Kas</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Seitz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Smeets</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sternheim</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tenconi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>van Elburg</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van Furth</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zipfel</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Eating disorders: the big issue.</article-title>
            <source>Lancet Psychiatry</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>4</issue>
            <fpage>313</fpage>
            <page-range>313-5</page-range>
            <pub-id pub-id-type="pmid">27063378</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Lin</surname>
                <given-names>KC</given-names>
              </name>
              <name>
                <surname>Shen</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Gau</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of DSM-5 mental disorders in a nationally representative sample of children in Taiwan: methodology and main findings.</article-title>
            <source>Epidemiol Psychiatr Sci</source>
            <year>2019</year>
            <month>Jan</month>
            <day>30</day>
            <volume>29</volume>
            <fpage>e15</fpage>
            <pub-id pub-id-type="pmid">30696515</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chua</surname>
                <given-names>SN</given-names>
              </name>
              <name>
                <surname>Fitzsimmons-Craft</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Austin</surname>
                <given-names>SB</given-names>
              </name>
              <name>
                <surname>Wilfley</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>CB</given-names>
              </name>
            </person-group>
            <article-title>Estimated prevalence of eating disorders in Singapore.</article-title>
            <source>Int J Eat Disord</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>54</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-18</page-range>
            <pub-id pub-id-type="pmid">33314277</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hilbert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zenger</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eichler</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Br&#x000e4;hler</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Psychometric evaluation of the Eating Disorders in Youth-Questionnaire when used in adults: Prevalence estimates for symptoms of avoidant/restrictive food intake disorder and population norms.</article-title>
            <source>Int J Eat Disord</source>
            <year>2021</year>
            <month>Mar</month>
            <volume>54</volume>
            <issue>3</issue>
            <fpage>399</fpage>
            <page-range>399-408</page-range>
            <pub-id pub-id-type="pmid">33283329</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nicely</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Lane-Loney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Masciulli</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hollenbeak</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Ornstein</surname>
                <given-names>RM</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and characteristics of avoidant/restrictive food intake disorder in a cohort of young patients in day treatment for eating disorders.</article-title>
            <source>J Eat Disord</source>
            <year>2014</year>
            <volume>2</volume>
            <issue>1</issue>
            <fpage>21</fpage>
            <pub-id pub-id-type="pmid">25165558</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Ornstein</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Mammel</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Katzman</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Rome</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Malizio</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kearney</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>BT</given-names>
              </name>
            </person-group>
            <article-title>Characteristics of avoidant/restrictive food intake disorder in children and adolescents: a "new disorder" in DSM-5.</article-title>
            <source>J Adolesc Health</source>
            <year>2014</year>
            <month>Jul</month>
            <volume>55</volume>
            <issue>1</issue>
            <fpage>49</fpage>
            <page-range>49-52</page-range>
            <pub-id pub-id-type="pmid">24506978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Inoue</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Otani</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Iguchi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ishii</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Uchida</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Okada</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kitayama</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Koyanagi</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Suzuki</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Sumi</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Takamiya</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tsurumaru</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Nagamitsu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fukai</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fujii</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Matsuoka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Iwanami</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wakabayashi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sakuta</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of autism spectrum disorder and autistic traits in children with anorexia nervosa and avoidant/restrictive food intake disorder.</article-title>
            <source>Biopsychosoc Med</source>
            <year>2021</year>
            <month>May</month>
            <day>17</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <pub-id pub-id-type="pmid">34001197</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennedy</surname>
                <given-names>GA</given-names>
              </name>
              <name>
                <surname>Wick</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Keel</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Eating disorders in children: is avoidant-restrictive food intake disorder a feeding disorder or an eating disorder and what are the implications for treatment?</article-title>
            <source>F1000Res</source>
            <year>2018</year>
            <volume>7</volume>
            <fpage>88</fpage>
            <pub-id pub-id-type="pmid">29399331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harshman</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Jo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kuhnle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Hauser</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Murray</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>A Moving Target: How We Define Avoidant/Restrictive Food Intake Disorder Can Double Its Prevalence.</article-title>
            <source>J Clin Psychiatry</source>
            <year>2021</year>
            <month>Sep</month>
            <day>07</day>
            <volume>82</volume>
            <issue>5</issue>
            <pub-id pub-id-type="pmid">34496463</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Frank</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kullmann</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Veit</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Food related processes in the insular cortex.</article-title>
            <source>Front Hum Neurosci</source>
            <year>2013</year>
            <volume>7</volume>
            <fpage>499</fpage>
            <pub-id pub-id-type="pmid">23986683</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Steiger</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Eating disorders and the serotonin connection: state, trait and developmental effects.</article-title>
            <source>J Psychiatry Neurosci</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>29</volume>
            <issue>1</issue>
            <fpage>20</fpage>
            <page-range>20-9</page-range>
            <pub-id pub-id-type="pmid">14719047</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kambanis</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Assessment and Treatment of Avoidant/Restrictive Food Intake Disorder.</article-title>
            <source>Curr Psychiatry Rep</source>
            <year>2023</year>
            <month>Feb</month>
            <volume>25</volume>
            <issue>2</issue>
            <fpage>53</fpage>
            <page-range>53-64</page-range>
            <pub-id pub-id-type="pmid">36640211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Seetharaman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fields</surname>
                <given-names>EL</given-names>
              </name>
            </person-group>
            <article-title>Avoidant/Restrictive Food Intake Disorder.</article-title>
            <source>Pediatr Rev</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>41</volume>
            <issue>12</issue>
            <fpage>613</fpage>
            <page-range>613-622</page-range>
            <pub-id pub-id-type="pmid">33262151</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Katzman</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Zucker</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Avoidant Restrictive Food Intake Disorder.</article-title>
            <source>Psychiatr Clin North Am</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>42</volume>
            <issue>1</issue>
            <fpage>45</fpage>
            <page-range>45-57</page-range>
            <pub-id pub-id-type="pmid">30704639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lange</surname>
                <given-names>CRA</given-names>
              </name>
              <name>
                <surname>Ekedahl Fjertorp</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Holmer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wijk</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Wallin</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Long-term follow-up study of low-weight avoidant restrictive food intake disorder compared with childhood-onset anorexia nervosa: Psychiatric and occupational outcome in 56 patients.</article-title>
            <source>Int J Eat Disord</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>435</fpage>
            <page-range>435-438</page-range>
            <pub-id pub-id-type="pmid">30741442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bourne</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bryant-Waugh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cook</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mandy</surname>
                <given-names>W</given-names>
              </name>
            </person-group>
            <article-title>Avoidant/restrictive food intake disorder: A systematic scoping review of the current literature.</article-title>
            <source>Psychiatry Res</source>
            <year>2020</year>
            <month>Jun</month>
            <volume>288</volume>
            <fpage>112961</fpage>
            <pub-id pub-id-type="pmid">32283448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bucher</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yadlosky</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>ARFID at 10&#x000a0;years: A Review of Medical, Nutritional and Psychological Evaluation and Management.</article-title>
            <source>Curr Gastroenterol Rep</source>
            <year>2023</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>12</issue>
            <fpage>421</fpage>
            <page-range>421-429</page-range>
            <pub-id pub-id-type="pmid">37755631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Murray</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Bailey</surname>
                <given-names>AP</given-names>
              </name>
              <name>
                <surname>Keshishian</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Silvernale</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Staller</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kuo</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Prevalence and Characteristics of Avoidant/Restrictive Food Intake Disorder in Adult Neurogastroenterology Patients.</article-title>
            <source>Clin Gastroenterol Hepatol</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>18</volume>
            <issue>9</issue>
            <fpage>1995</fpage>
            <page-range>1995-2002.e1</page-range>
            <pub-id pub-id-type="pmid">31669056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Makhzoumi</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Schreyer</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Laddaran</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Redgrave</surname>
                <given-names>GW</given-names>
              </name>
              <name>
                <surname>Guarda</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Hospital course of underweight youth with ARFID treated with a meal-based behavioral protocol in an inpatient-partial hospitalization program for eating disorders.</article-title>
            <source>Int J Eat Disord</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>428</fpage>
            <page-range>428-434</page-range>
            <pub-id pub-id-type="pmid">30779365</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Di Cara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Corallo</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cardile</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Calabr&#x000f2;</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Quartarone</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Buda</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cucinotta</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Avoidant Restrictive Food Intake Disorder: A Narrative Review of Types and Characteristics of Therapeutic Interventions.</article-title>
            <source>Children (Basel)</source>
            <year>2023</year>
            <month>Jul</month>
            <day>28</day>
            <volume>10</volume>
            <issue>8</issue>
            <pub-id pub-id-type="pmid">37628296</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gray</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Menzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schwartz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kaye</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>Mirtazapine and Weight Gain in Avoidant and Restrictive Food Intake Disorder.</article-title>
            <source>J Am Acad Child Adolesc Psychiatry</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>57</volume>
            <issue>4</issue>
            <fpage>288</fpage>
            <page-range>288-289</page-range>
            <pub-id pub-id-type="pmid">29588055</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brigham</surname>
                <given-names>KS</given-names>
              </name>
              <name>
                <surname>Manzo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Evaluation and Treatment of Avoidant/Restrictive Food Intake Disorder (ARFID) in Adolescents.</article-title>
            <source>Curr Pediatr Rep</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>107</fpage>
            <page-range>107-113</page-range>
            <pub-id pub-id-type="pmid">31134139</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spettigue</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Norris</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Obeid</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Treatment of children and adolescents with avoidant/restrictive food intake disorder: a case series examining the feasibility of family therapy and adjunctive treatments.</article-title>
            <source>J Eat Disord</source>
            <year>2018</year>
            <volume>6</volume>
            <fpage>20</fpage>
            <pub-id pub-id-type="pmid">30123505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brewerton</surname>
                <given-names>TD</given-names>
              </name>
              <name>
                <surname>D'Agostino</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Adjunctive Use of Olanzapine in the Treatment of Avoidant Restrictive Food Intake Disorder in Children and Adolescents in an Eating Disorders Program.</article-title>
            <source>J Child Adolesc Psychopharmacol</source>
            <year>2017</year>
            <month>Dec</month>
            <volume>27</volume>
            <issue>10</issue>
            <fpage>920</fpage>
            <page-range>920-922</page-range>
            <pub-id pub-id-type="pmid">29068721</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vanzhula</surname>
                <given-names>IA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martinelli</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Schreyer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Guarda</surname>
                <given-names>AS</given-names>
              </name>
            </person-group>
            <article-title>Inpatient hospital course and self-reported symptomatology in underweight adults with ARFID compared to age- and sex-matched controls with anorexia nervosa.</article-title>
            <source>J Eat Disord</source>
            <year>2023</year>
            <month>Nov</month>
            <day>20</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>206</fpage>
            <pub-id pub-id-type="pmid">37986115</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fjeldstad</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kvist</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Sj&#x000f6;gren</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Weight Gain in Adults with Avoidant/Restrictive Food Intake Disorder Compared to Restrictive Anorexia Nervosa-Pilot Findings from a Longitudinal Study.</article-title>
            <source>Nutrients</source>
            <year>2021</year>
            <month>Mar</month>
            <day>07</day>
            <volume>13</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">33799928</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Strandjord</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Sieke</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Richmond</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rome</surname>
                <given-names>ES</given-names>
              </name>
            </person-group>
            <article-title>Avoidant/Restrictive Food Intake Disorder: Illness and Hospital Course in Patients Hospitalized for Nutritional Insufficiency.</article-title>
            <source>J Adolesc Health</source>
            <year>2015</year>
            <month>Dec</month>
            <volume>57</volume>
            <issue>6</issue>
            <fpage>673</fpage>
            <page-range>673-8</page-range>
            <pub-id pub-id-type="pmid">26422290</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singer</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Sletten</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Opfer-Gehrking</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Brands</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Low</surname>
                <given-names>PA</given-names>
              </name>
            </person-group>
            <article-title>Postural tachycardia in children and adolescents: what is abnormal?</article-title>
            <source>J Pediatr</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>160</volume>
            <issue>2</issue>
            <fpage>222</fpage>
            <page-range>222-6</page-range>
            <pub-id pub-id-type="pmid">21996154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Raj</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Guzman</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Harvey</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Richer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schondorf</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Seifer</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Thibodeau-Jarry</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Sheldon</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Canadian Cardiovascular Society Position Statement on Postural Orthostatic Tachycardia Syndrome (POTS) and Related Disorders of Chronic Orthostatic Intolerance.</article-title>
            <source>Can J Cardiol</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>357</fpage>
            <page-range>357-372</page-range>
            <pub-id pub-id-type="pmid">32145864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r41">
          <label>41</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hornberger</surname>
                <given-names>LL</given-names>
              </name>
              <name>
                <surname>Lane</surname>
                <given-names>MA</given-names>
              </name>
              <collab>COMMITTEE ON ADOLESCENCE</collab>
            </person-group>
            <article-title>Identification and Management of Eating Disorders in Children and Adolescents.</article-title>
            <source>Pediatrics</source>
            <year>2021</year>
            <month>Jan</month>
            <volume>147</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">33386343</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r42">
          <label>42</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Crone</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Fochtmann</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Attia</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Boland</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Escobar</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fornari</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Guarda</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jackson-Triche</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Manzo</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Mascolo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Riddle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Seritan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Uniacke</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Zucker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Yager</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Craig</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Hong</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Medicus</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders.</article-title>
            <source>Am J Psychiatry</source>
            <year>2023</year>
            <month>Feb</month>
            <day>01</day>
            <volume>180</volume>
            <issue>2</issue>
            <fpage>167</fpage>
            <page-range>167-171</page-range>
            <pub-id pub-id-type="pmid">36722117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r43">
          <label>43</label>
          <element-citation publication-type="journal">
            <collab>Society for Adolescent Health and Medicine</collab>
            <article-title>Medical Management of Restrictive Eating Disorders in Adolescents and Young Adults.</article-title>
            <source>J Adolesc Health</source>
            <year>2022</year>
            <month>Nov</month>
            <volume>71</volume>
            <issue>5</issue>
            <fpage>648</fpage>
            <page-range>648-654</page-range>
            <pub-id pub-id-type="pmid">36058805</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r44">
          <label>44</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>Society for Adolescent Health and Medicine</collab>
              <name>
                <surname>Golden</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Katzman</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Sawyer</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ornstein</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Rome</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Kohn</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kreipe</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Position Paper of the Society for Adolescent Health and Medicine: medical management of restrictive eating disorders in adolescents and young adults.</article-title>
            <source>J Adolesc Health</source>
            <year>2015</year>
            <month>Jan</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>121</fpage>
            <page-range>121-5</page-range>
            <pub-id pub-id-type="pmid">25530605</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r45">
          <label>45</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zimmerman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Avoidant/Restrictive Food Intake Disorder (ARFID).</article-title>
            <source>Curr Probl Pediatr Adolesc Health Care</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>47</volume>
            <issue>4</issue>
            <fpage>95</fpage>
            <page-range>95-103</page-range>
            <pub-id pub-id-type="pmid">28532967</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r46">
          <label>46</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Norris</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Spettigue</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Katzman</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Update on eating disorders: current perspectives on avoidant/restrictive food intake disorder in children and youth.</article-title>
            <source>Neuropsychiatr Dis Treat</source>
            <year>2016</year>
            <volume>12</volume>
            <fpage>213</fpage>
            <page-range>213-8</page-range>
            <pub-id pub-id-type="pmid">26855577</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r47">
          <label>47</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kurz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>van Dyck</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Dremmel</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Munsch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hilbert</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Early-onset restrictive eating disturbances in primary school boys and girls.</article-title>
            <source>Eur Child Adolesc Psychiatry</source>
            <year>2015</year>
            <month>Jul</month>
            <volume>24</volume>
            <issue>7</issue>
            <fpage>779</fpage>
            <page-range>779-85</page-range>
            <pub-id pub-id-type="pmid">25296563</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r48">
          <label>48</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forman</surname>
                <given-names>SF</given-names>
              </name>
              <name>
                <surname>McKenzie</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hehn</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Monge</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Kapphahn</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Mammel</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Callahan</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Sigel</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Bravender</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rome</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Malizio</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Rosen</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Hergenroeder</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Buckelew</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Jay</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Lindenbaum</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rickert</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Garber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Golden</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Woods</surname>
                <given-names>ER</given-names>
              </name>
            </person-group>
            <article-title>Predictors of outcome at 1 year in adolescents with DSM-5 restrictive eating disorders: report of the national eating disorders quality improvement collaborative.</article-title>
            <source>J Adolesc Health</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>55</volume>
            <issue>6</issue>
            <fpage>750</fpage>
            <page-range>750-6</page-range>
            <pub-id pub-id-type="pmid">25200345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r49">
          <label>49</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Friars</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>McNicholas</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Assessment and management of cardiovascular complications in eating disorders.</article-title>
            <source>J Eat Disord</source>
            <year>2023</year>
            <month>Jan</month>
            <day>30</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>13</fpage>
            <pub-id pub-id-type="pmid">36717950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r50">
          <label>50</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Eddy</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Harshman</surname>
                <given-names>SG</given-names>
              </name>
              <name>
                <surname>Becker</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Bern</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Bryant-Waugh</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hilbert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Katzman</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Manzo</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Menzel</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ornstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Sally</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Serinsky</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Stubbs</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Walsh</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Zickgraf</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zucker</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Radcliffe ARFID Workgroup: Toward operationalization of research diagnostic criteria and directions for the field.</article-title>
            <source>Int J Eat Disord</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>52</volume>
            <issue>4</issue>
            <fpage>361</fpage>
            <page-range>361-366</page-range>
            <pub-id pub-id-type="pmid">30758864</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r51">
          <label>51</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Aulinas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marengi</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Galbiati</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Asanza</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Slattery</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mancuso</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Wons</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Micali</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Bern</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Eddy</surname>
                <given-names>KT</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lawson</surname>
                <given-names>EA</given-names>
              </name>
            </person-group>
            <article-title>Medical comorbidities and endocrine dysfunction in low-weight females with avoidant/restrictive food intake disorder compared to anorexia nervosa and healthy controls.</article-title>
            <source>Int J Eat Disord</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>631</fpage>
            <page-range>631-636</page-range>
            <pub-id pub-id-type="pmid">32198943</pub-id>
          </element-citation>
        </ref>
        <ref id="article-164812.r52">
          <label>52</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cucinotta</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Romano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Dipasquale</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>A Systematic Review to Manage Avoidant/Restrictive Food Intake Disorders in Pediatric Gastroenterological Practice.</article-title>
            <source>Healthcare (Basel)</source>
            <year>2023</year>
            <month>Aug</month>
            <day>10</day>
            <volume>11</volume>
            <issue>16</issue>
            <pub-id pub-id-type="pmid">37628443</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
